Macquarie Group LTD Ocular Therapeutix, Inc Transaction History
Macquarie Group LTD
- $86.4 Billion
- Q4 2024
A detailed history of Macquarie Group LTD transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Macquarie Group LTD holds 10,548 shares of OCUL stock, worth $75,945. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,548Holding current value
$75,945% of portfolio
0.0%Shares
9 transactions
Others Institutions Holding OCUL
# of Institutions
189Shares Held
132MCall Options Held
374KPut Options Held
179K-
Summer Road LLC West Palm Beach, FL13.9MShares$99.9 Million98.85% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.8MShares$92.4 Million4.83% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$91.9 Million17.98% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$82.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.48MShares$61.1 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $554M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...